Skip to main content

ZA-17 5mg (Bromocriptine Mesylate 5 mg)

Pill with imprint ZA-17 5mg is Tan & White, Capsule-shape and has been identified as Bromocriptine Mesylate 5 mg. It is supplied by Zydus Pharmaceuticals.

Bromocriptine is used in the treatment of hyperprolactinemia; parkinson's disease; acromegaly; diabetes, type 2 and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Bromocriptine 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ZA-17 5mg

Bromocriptine mesylate 5 mg ZA-17 5mg

Bromocriptine Mesylate

Imprint
ZA-17 5mg
Strength
5 mg
Color
Tan & White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents, Prolactin inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals
National Drug Code (NDC)
68382-0110
Inactive Ingredients
lactose monohydrate, magnesium stearate, maleic acid, silicon dioxide, titanium dioxide, carrageenan, hypromellose 2910 (15 mPa.s), ferric oxide red, potassium hydroxide, ferrosoferric oxide, butyl alcohol, alcohol, isopropyl alcohol, propylene glycol, water, shellac, ammonia

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.